Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Biohaven (BHVN) Equity Average (2021 - 2026)

Biohaven has reported Equity Average over the past 6 years, most recently at $90.8 million for Q1 2026.

  • Quarterly results put Equity Average at $90.8 million for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $90.8 million (changed N/A YoY), and the annual figure for FY2025 was $26.1 million, down 87.82%.
  • Equity Average reached $90.8 million in Q1 2026 per BHVN's latest filing, up from $17.5 million in the prior quarter.
  • Across five years, Equity Average topped out at $319.5 million in Q4 2022 and bottomed at -$579.5 million in Q3 2024.
  • Median Equity Average over the past 5 years was $40.4 million (2022), compared with a mean of $11.6 million.
  • The largest annual shift saw Equity Average soared 567.08% in 2023 before it plummeted 334855.49% in 2024.
  • Over 5 years, Equity Average stood at $319.5 million in 2022, then tumbled by 33.04% to $213.9 million in 2023, then tumbled by 370.81% to -$579.4 million in 2024, then surged by 103.01% to $17.5 million in 2025, then soared by 420.08% to $90.8 million in 2026.
  • Business Quant data shows Equity Average for BHVN at $90.8 million in Q1 2026, $17.5 million in Q4 2025, and $69.9 million in Q3 2025.